Iotrolan, nouveau produit de contraste non ionique hydrosoluble, en myélographieTANAKA, S.Yakuri to chiryo. 1986, Vol 14, Num 8, pp 389-404, issn 0386-3603Article

Iotrolan produit de contraste non ionique hydrosoluble dans la myélographieKAKINOKI, Y.Yakuri to chiryo. 1986, Vol 14, Num 8, pp 357-364, issn 0386-3603Article

Prospective study of safety of lower extremity phlebography with nonionic contrast mediumABURAHMA, A. F; POWELL, M; ROBINSON, P. A et al.The American journal of surgery. 1996, Vol 171, Num 2, pp 255-257, issn 0002-9610Article

Utilité clinique de l'iohexol dans l'angiographie cérébraleKODAMA, T; TAMURA, S; OGATA, N et al.Yakuri to chiryo. 1990, Vol 18, Num 1, pp 225-232, issn 0386-3603Article

Intravenous urography with a new non-ionic contrast media in a clinical phase III study: iopentol vs iohexolRASMUSSEN, F; DYREBORG, U; LARSEN, C et al.Clinical radiology. 1990, Vol 41, Num 1, pp 37-41, issn 0009-9260Article

New and old contrast agents: pharmacology, tissue opacification, and excretory urographySPATARO, R. F.Urologic radiology. 1988, Vol 10, Num 1, pp 2-5, issn 0171-1091Article

Atypical contrast reactions associated with systemic interleukin-2 therapyFISHMAN, J. E; ABERLE, D. R; MOLDAWER, N. P et al.American journal of roentgenology (1976). 1991, Vol 156, Num 4, pp 833-834, issn 0361-803XArticle

Nonionic vs ionic contrast media: what do the data tell us?LASSER, E. C; BERRY, C. C.American journal of roentgenology (1976). 1989, Vol 152, Num 5, pp 945-946, issn 0361-803X, 2 p.Article

Emploi du produit de contraste hydrosoluble non ionique, iohexol, dans la myélographie et les CT-ventriculo, cisterno-, myelo-graphiésKOBAYASHI, N; ONO, Y; MIYAUCHI, T et al.Yakuri to chiryo. 1987, Vol 15, Num 4, pp 197-211, issn 0386-3603Article

Comparison of histamine release effects of ionic and non-ionic radiographic contrast mediaSALEM, D. N; FINDLAY, S. R; ISNER, J. M et al.The American journal of medicine. 1986, Vol 80, Num 3, pp 382-384, issn 0002-9343Article

Efficacité du iotrolan, produit de contraste hydrosoluble non ionique, en myélographie et CT-ventriculocisternographie et CT-myélographieAOKI, S.Yakuri to chiryo. 1986, Vol 14, Num 7, pp 505-512, issn 0386-3603Article

Effects of nonionic contrast media on platelet aggregation assessment by particle counting with laser-light scatteringOGAWA, Takanori; FUJII, Satoshi; URASAWA, Kazushi et al.Japanese heart journal. 2001, Vol 42, Num 1, pp 115-124, issn 0021-4868Article

Verträglichkeit nichtionischer Kontrastmittel―Ergebnis einer multizentrischen Doppelbindstudie = Tolerability of nonionic contrast media results of a multicentre double blind studySCHMIEDEL, E.Aktuelle Radiologie. 1992, Vol 2, Num 3, pp 148-152, issn 0939-267XArticle

Iopamidol in cardioangiography: a retrospective, multicenter study. II : Paediatric patientsBALLERINI, L; BARBARESI, F; PASSONI, F et al.International journal of cardiac imaging. 1992, Vol 8, Num 1, pp 45-52, issn 0167-9899Article

A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: comparison of adverse effectsWOLF, G. L; ARENSON, R. L; CROSS, A. P et al.American journal of roentgenology (1976). 1989, Vol 152, Num 5, pp 939-944, issn 0361-803X, 6 p.Article

Etude clinique du iotrolan, dimère non ionique dans la CT-cisternographie et la CT-myélographieMIYASAKA, K.Yakuri to chiryo. 1986, Vol 14, Num 8, pp 373-379, issn 0386-3603Article

Kontrastmittelzwischenfall mit Iohexol (Omnipaque) mit in vivo nachgewiesener Monozytenaktivierung = Réaction de contraste au iohexol (omnipaque) avec démonstration in vivo de l'activation des monocytes = Contrast reaction to iohexol (omnipaque) with in vivo demonstration of monocyte activationBOLZ, V. K.-D; BOLLE, R; DUE, J et al.RöFo. Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin. 1987, Vol 146, Num 3, pp 347-349, issn 0340-1618Article

Intravascular immune hemolysis caused by the contrast medium iomeprolMAYER, Beate; LEO, Albrecht; HERZIGER, Angela et al.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 10, pp 2141-2144, issn 0041-1132, 4 p., 1Article

Érythème pigmenté fixe à l'iodixanol (Visipaque®) = Fixed drug eruption caused by iodixanolLE BETTER, C; FRAITAG, S; JACQUOT, C et al.Annales de dermatologie et de vénéréologie. 2008, Vol 135, Num 10, pp 684-685, issn 0151-9638, 2 p.Article

Analysis of the contrast agent iopamidol in serum by capillary electrophoresisSHIHABI, Z. K; ROCCO, M. V; HINSDALE, M. E et al.Journal of liquid chromatography. 1995, Vol 18, Num 18-19, pp 3825-3831, issn 0148-3919Article

Cost, corticosteroids, and contrast mediaDUNNICK, N. R; COHAN, R. H.American journal of roentgenology (1976). 1994, Vol 162, Num 3, pp 527-529, issn 0361-803XConference Paper

Addition of sodium to the nonionic contrast medium iohexol during coronary angiography in man : lack of electrocardiographic or hemodynamic effectsVIK-MO, H; BJØRKHAUG, A; DANIELSEN, R et al.Acta radiologica (1987). 1992, Vol 33, Num 5, pp 485-489, issn 0284-1851Article

Iomeprol vs iopamidol in intraarterial peripheral digital subtraction angiographyDACORONIAS, D; UGOLOTTI, U et al.Angiology. 1992, Vol 43, Num 9, pp 734-740, issn 0003-3197Article

Renal effects of iopentol and iohexol after intravenous injectionJAKOBSEN, J. A; KKOLBENSTVEDT, A. N; BERG, K. J et al.Acta radiologica (1987). 1991, Vol 32, Num 4, pp 320-324, issn 0284-1851Article

Konylikationen brachiocephaler Katleterangiographien bei Verwendung eines nicht-ionischen Kontrastmittels = Complications de l'artériographie cérébrale rétrograde avec un produit de contraste non ionique = Complications of retrograde brain angiography with a non ionic contrast mediumGROSS-FENGELS, W; MÖDDER, U; BEYER, D et al.Der Radiologe (Berlin. Print). 1987, Vol 27, Num 2, pp 83-88, issn 0033-832XArticle